Nanjing Aosaikang Medicinal Group is a research-based pharmaceutical company, which is located in the Science Park in Nanjing, China.

    Established in September 2005, Nanjing Aosaikang Medicinal Group is a hi-tech modern non-stated owned enterprise integrating the research, development, production, market promotion and sales of medicine, fine chemicals and health care products. With specialized mass production as well as outstanding research and development capacity, it continually launches new products into the market. Its products, currently manufactured, are grouped into four catogories of digestive, anti-tumor, antibiotics and cardiovascular.

    Covering an area of about 120,000m², the Group has three bases, namely, research and development base, production base and retail sales service base for pharmaceuticals. The research and development base i.e., Nanjing Haiguang Applied Chemistry Research Institute now focuses on the research of anti-tumor pharmaceuticals and proton pump inhibitors. The production promises: : Jiangsu Assailant Pharmaceutical Co., Ltd. and Yangzhou Aosaikang Pharmaceutical Co., Ltd. mainly produce new pharmaceuticals independently researched and developed. The retail sales service base for pharmaceuticals, i.e., Hainan Haimai Pharmaceutical Co., Ltd. passed GSP certification of State Food and Drug Administration in 2004.

    Nanjing Aosaikang Medicinal Group is comprises of following subsidiary companies:
- Nanjing Haiguang Applied Chemistry Research Institute
Principle operation: research and development of new drugs; academic activities and exchange program; technical consultation service and transfer.

- Yangzhou Aosaikang Pharmaceutical Co., Ltd.
Principle operation: production facilities which currently produces more than fifty formulation drugs in category of digestion, anti-cancer, cardiology, antibiotics and others.

- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
    A new-built production base, with a total area of 120000 ㎡. It is currently one of the pharm companies in China with varieties of oncology products and also PPI injection drugs.
    It has GMP certifications for Bulk drugs, lyophilized powder products and injection products. The new premises is currently involved in the manufacture of lyophilized powder injection of anti-tumor drugs, anti-biotics, oral solid preparations and cephalosporin range drugs.
We have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

- Haitian International Trading Co., Ltd.
    Principle operation: import and export activities, international business development, purchasing and handling import of packing materials, bulk drugs and intermediates.